Pancreatic cancer vaccine shows promise in trial
Pancreatic cancer vaccine shows promise in trial
Pancreatic cancer vaccine shows promise in trial
Key points
اہم نکات
मुख्य बातें
- An experimental vaccine for pancreatic cancer has shown promise in an early clinical trial, Medical News Today reports.
- The vaccine is designed to train the immune system to recognise and attack pancreatic tumour cells, one of the hardest cancers to treat.
- Researchers say the early results offer fresh hope, though larger trials are still needed before it could reach patients.
- An experimental vaccine for pancreatic cancer has shown promise in an early clinical trial, Medical News Today reports.
- The vaccine is designed to train the immune system to recognise and attack pancreatic tumour cells, one of the hardest cancers to treat.
- Researchers say the early results offer fresh hope, though larger trials are still needed before it could reach patients.
- An experimental vaccine for pancreatic cancer has shown promise in an early clinical trial, Medical News Today reports.
- The vaccine is designed to train the immune system to recognise and attack pancreatic tumour cells, one of the hardest cancers to treat.
- Researchers say the early results offer fresh hope, though larger trials are still needed before it could reach patients.
An experimental vaccine for pancreatic cancer has shown promise in an early clinical trial, Medical News Today reports. The vaccine is designed to train the immune system to recognise and attack pancreatic tumour cells, one of the hardest cancers to treat. Researchers say the early results offer fresh hope, though larger trials are still needed before it could reach patients.
An experimental vaccine for pancreatic cancer has shown promise in an early clinical trial, Medical News Today reports. The vaccine is designed to train the immune system to recognise and attack pancreatic tumour cells, one of the hardest cancers to treat. Researchers say the early results offer fresh hope, though larger trials are still needed before it could reach patients.
An experimental vaccine for pancreatic cancer has shown promise in an early clinical trial, Medical News Today reports. The vaccine is designed to train the immune system to recognise and attack pancreatic tumour cells, one of the hardest cancers to treat. Researchers say the early results offer fresh hope, though larger trials are still needed before it could reach patients.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।